Aridis Pharmaceuticals Inc

NASDAQ:ARDS  
3.94
+0.05 (+1.28%)
Earnings Announcements

Aridis Pharmaceuticals Announces Second Quarter 2021 Results

Published: 08/12/2021 13:28 GMT
Aridis Pharmaceuticals Inc (ARDS) - Aridis Pharmaceuticals Announces Second Quarter 2021 Results.
Qtrly Loss per Share $0.49.
Q2 Earnings per Share View $-0.63 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.45 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $1.6 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.